Organization Overview
131i-lipiodol (Lipiodol) (1 trial)
alendronic acid (fosamax) (1 trial)
amantadine (symmetrel) (1 trial)
atazanavir (reyataz) (3 trials)
dolutegravir (tivicay) (3 trials)
enfuvirtide (fuzeon) (2 trials)
etravirine (intelence) (3 trials)
fluconazole (diflucan) (2 trials)
flucytosine (ancobon) (1 trial)
aldesleukin (Proleukin) (4 trials)
amprenavir (agenerase) (1 trial)
boceprevir (victrelis) (2 trials)
canakinumab (ilaris) (1 trial)
fosamprenavir (lexiva) (1 trial)
grazoprevir (zepatier) (1 trial)
gtu-multhiv b vaccine (3 trials)
inactivated influenza vaccine (1 trial)
interferon gamma-1b (actimmune) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Castleman Disease (Phase 2)
Cocaine-Related Disorders (Phase 2)
Coinfection (Phase 2)
Communicable Diseases (Phase 3)
Cryoglobulinemia (Phase 2)
Depressive Disorder (Phase 3)
End Stage Liver Disease (Phase 2)
Fever (Phase 3)
Fibrosis (Phase 3)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
Hepatitis, Chronic (Phase 3)
Hepatitis, Viral, Human (Phase 3)
Herpes Genitalis (Phase 2)
HIV-Associated Lipodystrophy Syndrome (Phase 4)
HIV Infections (Phase 4)
Hyperlipidemias (Phase 4)
Hyperlipoproteinemias (Phase 4)
Hyperplasia (Phase 2)
Infections (Phase 3)
Influenza, Human (Phase 2)
Insulin Resistance (Phase 3)
Leukoencephalopathies (Phase 2)
Lipodystrophy (Phase 4)
Liver Cirrhosis (Phase 3)
Liver Cirrhosis, Experimental (Phase 2)
Liver Diseases (Phase 2)
Liver Failure (Phase 2)
Lymphoma (Phase 2)
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Meningitis (Phase 3)
Meningitis, Cryptococcal (Phase 3)
Osteoporosis (Phase 3)
Renal Insufficiency (Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Substance-Related Disorders (Phase 3)
Syndrome (Phase 4)
Tobacco Use Disorder (Phase 3)
Tuberculosis (Phase 4)
Tuberculosis, Pulmonary (Phase 2)
Ulcer (Phase 2)
Vasculitis (Phase 2)
Viremia (Phase 3)
Virus Diseases (Phase 3)
Xeroderma Pigmentosum (Phase 2)
Yellow Fever (Phase 3)